COMPANY
AMPHASTAR PHARMACEUTICALS, INC.
AMPHASTAR PHARMACEUTICALS, INC.: marketing authorisation holder, US labeler for Glucagon, Ganirelix, Teriparatide, Vasopressin, as stated by public registers.
Also written as: Amphastar Pharmaceuticals, Inc..
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Glucagon | BAQSIMI (DIN 02492415), Marketed Regulator Health Canada |
|---|
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Ganirelix | Ganirelix Acetate, ANDA Regulator openFDA |
|---|---|
| Glucagon | Baqsimi, NDA Regulator openFDA |
| Glucagon | Glucagon, ANDA Regulator openFDA |
| Teriparatide | Teriparatide, ANDA Regulator openFDA |
| Vasopressin | Vasopressin, ANDA Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.